BLISSGVS
Invest Now

Bliss GVS Pharma Share Price
₹124.87 +1.66 (1.35%)
20 Apr, 2025 17:20
Start SIP in
BLISSGVS
Performance
- Low
- ₹123
- High
- ₹127
- 52 Week Low
- ₹92
- 52 Week High
- ₹186
- Open Price₹123
- Previous Close₹123
- Volume334,016
Investment Returns
- Over 1 Month + 4.08%
- Over 3 Month -22.42%
- Over 6 Month -10.07%
- Over 1 Year + 13.52%
Smart Investing Starts Here Start SIP with Bliss GVS Pharma for Steady Growth!
Bliss GVS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 22.1
- PEG Ratio
- -0.7
- Market Cap Cr
- 1,316
- P/B Ratio
- 1.3
- Average True Range
- 6.22
- EPS
- 7.63
- Dividend Yield
- 0.4
- MACD Signal
- -2.68
- RSI
- 52.26
- MFI
- 44.44
Bliss GVS Pharma Financials
Bliss GVS Pharma Technicals
EMA & SMA
Current Price
₹124.87
+
1.66
(1.35%)

-
- Bearish Moving Average 7
-
- Bullish Moving Average 9
- 20 Day
- ₹121.86
- 50 Day
- ₹128.37
- 100 Day
- ₹133.66
- 200 Day
- ₹131.92
Resistance and Support
124.66
- R3 130.60
- R2 128.55
- R1 126.71
- S1 122.82
- S2 120.77
- S3 118.93
Bliss GVS Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-28 | Quarterly Results & Others | To consider other business matters. per share(50%)Dividend |
2024-10-24 | Quarterly Results | |
2024-07-24 | Quarterly Results | |
2024-05-02 | Audited Results & Final Dividend | |
2024-01-23 | Quarterly Results |
Bliss GVS Pharma F&O
About Bliss GVS Pharma
- NSE Symbol
- BLISSGVS
- BSE Symbol
- 506197
- Managing Director
- Mr. Gagan Harsh Sharma
- ISIN
- INE416D01022
Similar Stocks to Bliss GVS Pharma
Bliss GVS Pharma FAQs
Bliss GVS Pharma share price is ₹124 As on 20 April, 2025 | 17:06
The Market Cap of Bliss GVS Pharma is ₹1315.8 Cr As on 20 April, 2025 | 17:06
The P/E ratio of Bliss GVS Pharma is 22.1 As on 20 April, 2025 | 17:06
The PB ratio of Bliss GVS Pharma is 1.3 As on 20 April, 2025 | 17:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.